Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.6500 (-0.69%) ($8.6500 - $8.6500) on Thu. Jul. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.22% (three month average) | RSI | 76 | Latest Price | $8.6500(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 18.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XAR(31%) XLC(30%) IVE(29%) XBI(29%) ARKK(28%) | Factors Impacting ATRA price | ATRA will decline at least -3.11% in a week (0% probabilities). UNG(-25%) EDOC(-24%) USO(-17%) TIP(-12%) XOP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.11% (StdDev 6.22%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.43(2.61%) | 10 Day Moving Average | $7.83(10.47%) | 20 Day Moving Average | $6.81(27.02%) | To recent high | -4.3% | To recent low | 84.4% | Market Cap | $643m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |